BIO-B
Bio-Rad Laboratories Inc
365.10$
+0.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.5% | 11.9% | 11.4% | 15.3% | 25.2% | 18.6% | 22.2% | 17.9% | 18.5% | 23.8% | 18.3% | 15.2% | 19.0% | |
| 5.9% | 5.5% | 6.1% | 5.7% | 6.0% | 7.4% | 6.5% | -5.8% | 6.8% | 6.1% | 6.9% | 6.3% | 6.5% | |
| 2.5% | 2.4% | 2.5% | 2.3% | 2.4% | 2.5% | 2.6% | -2.3% | 2.3% | 2.3% | 2.5% | 2.2% | 2.3% | |
| -11.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.4% | -1.2% | 8.8% | -106.4% | 34.0% | 8.5% | 7.4% | -6.7% | -15.7% | 36.7% | -28.5% | 0.4% | -0.5% | |
| 7.0% | 6.2% | 6.6% | 6.6% | 9.8% | 6.4% | 5.9% | 7.0% | 4.9% | 6.6% | 5.1% | 4.9% | 5.4% | |
| -1.5% | 10.6% | -7.1% | -4.8% | -8.6% | -4.6% | 0.5% | -17.7% | -6.6% | -4.9% | -15.7% | -10.2% | -9.2% | |
| 0.7% | 12,542.7% | 2.6% | – | 2.4% | – | – | 7.5% | – | – | 5.6% | 2.4% | – | |
| -3.4% | -29.4% | -0.8% | -15.8% | -15.1% | 0.0% | -17.4% | -21.5% | -8.2% | 0.0% | -8.1% | -4.8% | -5.1% | |
| 0.0% | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -4.2% | -29.5% | 0.0% | -15.1% | -14.8% | -3.9% | -16.7% | -20.9% | -8.0% | 0.5% | -7.4% | -4.3% | -4.7% | |
| 10.7% | -7.9% | 4.8% | -4.1% | 0.7% | 11.6% | 5.7% | -23.2% | 4.1% | 19.0% | -3.9% | 1.5% | 5.6% | |
| 8.5% | 5.7% | 4.8% | 8.7% | 15.4% | 12.2% | 16.3% | 10.9% | 13.7% | 17.2% | 13.2% | 10.2% | 13.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.